Zivo Bioscience Inc's ticker is ZIVO and the CUSIP is 98978N101. A total of 2 filers reported holding Zivo Bioscience Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,470 | -73.6% | 21,900 | -50.8% | 0.00% | -40.0% |
| Q2 2023 | $107,690 | -32.3% | 44,500 | -21.6% | 0.01% | -68.8% |
| Q3 2022 | $159,000 | -28.7% | 56,770 | 0.0% | 0.02% | -27.3% |
| Q2 2022 | $223,000 | +1.4% | 56,770 | 0.0% | 0.02% | +10.0% |
| Q1 2022 | $220,000 | +35.0% | 56,770 | 0.0% | 0.02% | +33.3% |
| Q4 2021 | $163,000 | – | 56,770 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Schechter Investment Advisors, LLC | 21,900 | $28,470 | 0.00% |
| Column Capital Advisors, LLC | 12,000 | $15,600 | 0.00% |